Daiichi Sankyo Company, Limited announced on September 1 details of the application for its Take a New Challenge for Drug Discovery (TaNeDS) Global Programme 2014, a collaborative drug discovery initiative for universities and research institutes in ... Individual.com, 20 hours ago
Daiichi Sankyo Espha Receives Manufacturing and Marketing License in Japan for Levofloxacin Tablets 250mg/500mg and Granules 10% DSEP - Noodls, 20 hours ago
DAIICHI SANKYO : Further Expands TaNeDS Collaborative Drug Discovery Program in Europe - 4 Traders, 20 hours ago
3 images for "daiichi sankyo company"
Sun Pharma agreed to buy Ranbaxy for $3.2 billion in stock from its Japanese parent Daiichi Sankyo in a deal that would create the world's fifth largest generic drugmaker. Photo: Bloomberg New Delhi: India's antitrust regulator has ordered a ...Livemint.com, 4 days ago Sun Pharma to buy Ranbaxy for USD 4 billion in all-share deal NewKerala.com, 1 week ago
NEW DELHI: , which is in the process of acquiring control of Ranbaxy Laboratories from Daiichi Sankyo, will soon put its purchase to work through the exclusive marketing opportunity offered by two drugs in the US, rationalising research and other ...Economic Times, 3 weeks ago Sun Pharma banks on Daiichi Sankyo to enter Japan market: Reports India Infoline, 3 weeks ago
Sun Pharmaceuticals is reportedly planning to enter the Japanese market riding on its association with Daiichi Sankyo from which it is buying Ranbaxy Laboratories. The Economic Times has reported that the drug company is likely to introduce its ...Pharmaceutical Business Review, 3 weeks ago Bharat Book Bureau: Global Pharmaceutical and Biotechnology Outlook 2014 - Japan Pharma Pharmacy Choice, 2 weeks ago SUN PLANS TO RISE IN JAPAN'S PHARMA MARKET Pharmacy Choice, 2 weeks ago
The company will immediately stop all the new chemical research work, except the ongoing projects in imaging and anaesthetics solutions, Piramal Enterprises vice-chairperson Swati Piramal said. Photo: Mint The group, which focuses on drug ...Livemint.com, 5 days ago
Lupin's managing director says there are some synergies and a lot of duplication between the two companies Rs 7,855.09 crore Wockhardt's market cap Rs 56,645.49 crore-- Lupin's market cap Pharma major Lupin, which has been ...DNA India, 6 days ago
P . In their earlier conference call the company had mentioned about a subpoena that was issued to them however not disclosing the details and the quantum of the fines that they would have to pay. According to reports this fine is divided into two ...Moneycontrol.com, 1 week ago CCI worried about molecular effect of Sun-Ranbaxy merger Domain-B, 2 days ago Sun Pharma-Ranbaxy deal comes under CCI scanner Business Today India, 3 weeks ago Sun- Ranbaxy deal comes under CCI lens [Mail Today (India)] Pharmacy Choice, 3 weeks ago
BOSTON, MA — Authors of a new meta-analysis comparing a bivalirudin (Angiomax, the Medicines Company)-based regimen vs a heparin-based approach in patients undergoing PCI say they hope their paper helps the medical community to understand the ...Diabetes Care, 2 weeks ago
Sun Pharma's April-June net profit was 13.91 billion rupees ($227.73 million), compared with a net loss of 12.76 billion rupees a year earlier. (Reuters) Summary Sun Pharma's April-June net profit was 13.91 billion rupees ($227.73 million), ...Financial Express, 2 weeks ago Sun, Ranbaxy hire Mckinsey for merger assistance Rediff.com, 1 month ago Too Big To Ignore Businessworld India, 1 week ago Sun Pharma registers Rs 1391 crores profit in Q1 Bio Spectrum Asia, 2 weeks ago
Top Healthcare Talent, Companies and Brand Champions to be Honored September 18th New York, NY (PRWEB) August 20, 2014 The finalists are in for the sixth-annual PM360 Trailblazer Awards. PM360, a leading health-marketing industry trade ...Red Orbit, 1 week ago
on your WebpageAdd Widget >Get your members hooked!